Jim Tananbaum, the MD who has Made a Name for Himself as a Pharmaceutical Investor

Versatility is a must-have trait to have in leadership. Unfortunately, however, with the specialized nature of modern business, it is quite rare to find business leaders who exemplify this trait. One of the few who does is Foresite Capital founder and chief executive officer, Jim Tananbaum. The medical doctor has been involved as an investor in 21 companies involved in various spheres within the healthcare industry.

Mr. Tananbaum’s fascinating peculiarity and versatility are seen right from his educational background. He received a Bachelor of Science in Electrical Engineering and Bachelor of Science degree from Yale University. He then went on to the Massachusetts Institute of Technology where he received a Master of Science, in Health Sciences and Technology degree. He studied for his masters while concurrently attending Harvard Medical School, from where he was awarded a Doctor of Medicine (MD) degree. Immediately after he joined the MBA program at Harvard Business School, completing two years later. This 10-year long educational journey that straddled between the fields of engineering, medicine, and business adequately prepared Mr. Tananbaum to become the investor and leader he is today. Visit LinkedIn to know more.

Mr. Tananbaum’s entrepreneurial exploits did not begin with Foresite Capital. He had long before invested in two pharmaceutical companies that would go on to be significantly successful. The first, GelTex Pharmaceuticals was worth a few million dollars when he invested in it. By the time of its sale, however, it was valued at $1.6 billion. The other company that he had founded was Theravance. He served at the company’s helm for three years, a period which saw its fortunes and value rise significantly. Theravance is still a significant player in the pharmaceutical industry till this day. Before settling at Foresite Capital, Mr. Tananbaum co-founded and managed Prospect Venture Partners.

Due to his ability to deliver, Mr. Jim Tananbaum has been invited to sit on a number of companies’ boards of directors. He sits on the board of Tarsa Therapeutics and also serves as an investor to Amerigroup, Amira Pharmaceuticals, and Jazz Pharmaceuticals. Further, he also sits on the advisory boards of Yale School of Engineering and the Harvard-MIT Health Sciences and Technology program.

See more: https://inc42.com/buzz/forbes-midas-top-100-investors-2017/

Madison Street Capital wins another Award from the M&A Advisors

The M&A Advisors is an organization that has been recognizing the outstanding work of enterprises that deal with M&A activities. The foundation recently named companies that won awards in its 11th the Annual Turnaround Awards. Madison Street Capital was honored as this year’s Restructuring Deal of the Year Award winner. The M&A Advisor will reward the winners on March 23rd at Black Tie Gala that will be at The Colony Hotel, which is located in Palm Beach, Florida.


M&A Advisor’s CEO and president, David Fergusson, said that the foundation is happy to be recognizing the industry’s leading companies, turnabout transactions, deal makers, and professionals. Madison Street Capital managed to be selected as a winner in a category that had over 300 highly performing competitors. The CEO believes that the organization is gratified to honor Madison Street Capital through its top distressed investing award. The enterprise is now recognized as the best provider of distresses investing and reorganization solutions.


Madison Street Capital’s CEO, Charles Botchway, said that the firm highly appreciates being named as the Restructuring Deal of the Year Award winner. According to him, the company provides excellent services since it has professionals who are dedicated to their work and have a sound understanding of the industry. The staff works hard to deliver the best services every year.


The Awards Gala that has been planned by M&A Advisors will be held together with the Distressed Investing Summit of 2017. The event will be big since it will be attended by over 200 professionals in the industry. The opening night of the conference is scheduled to be at Mar-A-Lago Club, and awarding gala, the summit, and the closing party will be hosted at the at Colony Hotel.


Madison Street Capital is renowned as one of the world’s most trusted providers of international investment banking services. The company offers its wide array of solutions with integrity, leadership, and excellence. The enterprise has developed outstanding expertise in determining the worth of private and public businesses, offering financial advice to companies, as well as merger and acquisitions. Madison Street Capital reputation stands outs due to its dedications to assist clients in reaching international markets and also gaining significant profits. The firm understands that emerging market are a reliable platform that can be used in enhancing the global growth of an enterprise. It is dedicated to offering its services with high standards and professionalism.